Open AccessAdjuvant chemotherapy is associated with improved survival in patients with nodal metastases after neoadjuvant therapy and esophagectomy
Author(s) -
Justin Drake,
Kurt W. Tauer,
David C. Portnoy,
Benny Weksler
Publication year - 2019
Publication title -
journal of thoracic disease
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.682
H-Index - 60
eISSN - 2077-6624
pISSN - 2072-1439
DOI - 10.21037/jtd.2019.05.66
Subject(s) - medicine , esophagectomy , oncology , esophageal cancer , chemotherapy , chemoradiotherapy , neoadjuvant therapy , cohort , lymph node , adenocarcinoma , adjuvant therapy , cancer , surgery , breast cancer
Studies supporting adjuvant chemotherapy after complete resection of esophageal cancer are scarce, and current clinical guidelines recommend either adjuvant chemotherapy or observation. We aimed to clarify the role of adjuvant chemotherapy in patients found to have persistent nodal metastases after neoadjuvant chemoradiation and complete resection of esophageal adenocarcinoma.